The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis MJM Gooden, GH de Bock, N Leffers, T Daemen, HW Nijman British journal of cancer 105 (1), 93-103, 2011 | 1379 | 2011 |
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system G Storm, SO Belliot, T Daemen, DD Lasic Advanced drug delivery reviews 17 (1), 31-48, 1995 | 1178 | 1995 |
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer N Leffers, MJM Gooden, RA de Jong, BN Hoogeboom, KA ten Hoor, ... Cancer Immunology, Immunotherapy 58, 449-459, 2009 | 551 | 2009 |
A potential role of macrophage activation in the treatment of cancer AH Klimp, EGE De Vries, GL Scherphof, T Daemen Critical reviews in oncology/hematology 44 (2), 143-161, 2002 | 483 | 2002 |
The virosome concept for influenza vaccines A Huckriede, L Bungener, T Stegmann, T Daemen, J Medema, ... Vaccine 23, S26-S38, 2005 | 335 | 2005 |
Myeloid derived suppressor cells—an overview of combat strategies to increase immunotherapy efficacy O Draghiciu, J Lubbers, HW Nijman, T Daemen Oncoimmunology 4 (1), e954829, 2015 | 283 | 2015 |
Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages AH Klimp, H Hollema, C Kempinga, AGJ van der Zee, EGE de Vries, ... Cancer research 61 (19), 7305-7309, 2001 | 278 | 2001 |
Liposomal doxorubicin‐induced toxicity: Depletion and impairment of phagocytic activity of liver macrophages T Daemen, G Hofstede, MT Ten Kate, IAJM Bakker‐Woudenberg, ... International journal of cancer 61 (5), 716-721, 1995 | 199 | 1995 |
Virosome-mediated delivery of protein antigens to dendritic cells L Bungener, K Serre, L Bijl, L Leserman, J Wilschut, T Daemen, P Machy Vaccine 20 (17-18), 2287-2295, 2002 | 187 | 2002 |
Immunization with a P53 synthetic long peptide vaccine induces P53‐specific immune responses in ovarian cancer patients, a phase II trial N Leffers, AJA Lambeck, MJM Gooden, BN Hoogeboom, R Wolf, ... International Journal of Cancer 125 (9), 2104-2113, 2009 | 174 | 2009 |
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer FL Komdeur, TM Prins, S van de Wall, A Plat, GBA Wisman, H Hollema, ... Oncoimmunology 6 (9), e1338230, 2017 | 165 | 2017 |
Vaccination against oncoproteins of HPV16 for noninvasive vulvar/vaginal lesions: lesion clearance is related to the strength of the T-cell response MIE van Poelgeest, MJP Welters, R Vermeij, LFM Stynenbosch, NM Loof, ... Clinical Cancer Research 22 (10), 2342-2350, 2016 | 161 | 2016 |
Frequencies and role of regulatory T cells in patients with (pre) malignant cervical neoplasia J Visser, HW Nijman, BN Hoogenboom, P Jager, D Van Baarle, ... Clinical & Experimental Immunology 150 (2), 199-209, 2007 | 151 | 2007 |
Virosomes for antigen and DNA delivery T Daemen, A de Mare, L Bungener, J de Jonge, A Huckriede, J Wilschut Advanced drug delivery reviews 57 (3), 451-463, 2005 | 149 | 2005 |
Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7 AJA Lambeck, APG Crijns, N Leffers, WJ Sluiter, KA ten Hoor, M Braid, ... Clinical Cancer Research 13 (8), 2385-2391, 2007 | 141 | 2007 |
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity L Bungener, A Huckriede, A de Mare, J de Vries-Idema, J Wilschut, ... Vaccine 23 (10), 1232-1241, 2005 | 123 | 2005 |
Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes A Arkema, A Huckriede, P Schoen, J Wilschut, T Daemen Vaccine 18 (14), 1327-1333, 2000 | 118 | 2000 |
Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication O Draghiciu, HW Nijman, BN Hoogeboom, T Meijerhof, T Daemen Oncoimmunology 4 (3), e989764, 2015 | 113 | 2015 |
Potentiation of a p53‐SLP vaccine by cyclophosphamide in ovarian cancer: a single‐arm phase II study R Vermeij, N Leffers, BN Hoogeboom, ILE Hamming, R Wolf, ... International Journal of Cancer 131 (5), E670-E680, 2012 | 112 | 2012 |
In Vitro Activation of Rat Liver Macrophages to Tumoricidal Activity by Free or Liposome-encapsulated Muramyl Dipeptide T Daemen, A Veninga, FH Roerdink, GL Scherphof Cancer research 46 (9), 4330-4335, 1986 | 109 | 1986 |